Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/21/1994 | CN1092313A Anti-catching cold Chinese traditional medicine oral liquid and preparing method |
09/21/1994 | CN1092302A Tablet of moleplant seed |
09/20/1994 | US5349068 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents |
09/20/1994 | US5348952 Antibiotics for antiinflammatory agents, degenerative diseases caused by proteolytic enzymes and respiratory system disorders |
09/20/1994 | US5348951 Cephalosporins |
09/20/1994 | US5348949 Method of preparing N-oxo-tetrahydro-β-carbolines |
09/20/1994 | US5348940 Fungicidal antibiotics |
09/20/1994 | US5348748 Pulsatile once-a-day delivery systems for minocycline |
09/19/1994 | CA2119175A1 Nucleic acid pharmaceuticals |
09/17/1994 | CA2118961A1 Novel 2-thiosubstituted carbapenems |
09/15/1994 | WO1994020540A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS |
09/15/1994 | WO1994020538A1 Extraction of cell-bound protein from bordetella |
09/15/1994 | WO1994020532A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
09/15/1994 | WO1994020528A1 Inhibitors of herpes viral ribonucleotide reductase |
09/15/1994 | WO1994020520A1 Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
09/15/1994 | WO1994020516A1 New sulfated lyso-ganglioside derivatives |
09/15/1994 | WO1994020515A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
09/15/1994 | WO1994020505A1 Crystalline ceftiofur free acid |
09/15/1994 | WO1994020504A1 2-acyloxycephem derivatives as elastase inhibitors |
09/15/1994 | WO1994020141A1 Therapeutic strategies for immunoinfective cluster virus infections |
09/15/1994 | WO1994020138A1 Recombinant epstein-barr virus protein and its use in vaccine |
09/15/1994 | WO1994020137A1 Production of human papillomavirus capsid protein and virus-like particles |
09/15/1994 | WO1994020135A1 Vaccines expressed in plants |
09/15/1994 | WO1994020133A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
09/15/1994 | WO1994020131A1 Method of treating hepatitis c in non-responders to interferon treatment |
09/15/1994 | WO1994020119A1 Therapeutic compositions containing a lithium compound and silica |
09/15/1994 | WO1994020110A1 Use of antiepileptics such as carbamazepine and oxcarbazepine for treating aids-related neural disorders |
09/15/1994 | WO1994020108A1 Use of lamotrigine for treating aids-related neural disorders |
09/15/1994 | WO1994020103A1 Use of riluzole for treating aids-related neural disorders |
09/15/1994 | WO1994020085A1 Methods and compositions for inhibition of angiogenesis |
09/15/1994 | WO1994020082A1 Use of terbinafine for the therapeutic treatment of pneumocystosis |
09/15/1994 | WO1994020062A2 Balanoids as protein kinase c inhibitors |
09/15/1994 | WO1994019945A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
09/15/1994 | WO1994019943A1 Ionene polymers as microbicides |
09/15/1994 | WO1994017091A3 Foldback triplex-forming oligonucleotides |
09/15/1994 | WO1994011010A3 Compositions of oak bark extract, related synthetic compositions, and method of using same |
09/15/1994 | WO1994004688A3 Cationic peptides and method for production |
09/15/1994 | CA2157900A1 Therapeutic strategies for immunoinfective cluster virus infections |
09/15/1994 | CA2157594A1 Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
09/15/1994 | CA2157412A1 Balanoids |
09/15/1994 | CA2157359A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
09/15/1994 | CA2157357A1 New sulfated lyso-ganglioside derivatives |
09/15/1994 | CA2156719A1 Recombinant epstein-barr virus protein and its use in vaccine |
09/15/1994 | CA2154573A1 Use of anticonvulsants for the treatment of neuro-sida |
09/15/1994 | CA2154571A1 Use of lamotrigine for the treatment of neuro-sida |
09/15/1994 | CA2118422A1 2 acyloxycephem derivatives |
09/14/1994 | EP0614981A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
09/14/1994 | EP0614980A1 TAT transdominant variants from human Immunodeficiency virus |
09/14/1994 | EP0614979A1 Hog cholera virus vaccine and diagnostic |
09/14/1994 | EP0614910A1 Streptogramines in purified form, their preparation and pharmaceutical compositions comprising them |
09/14/1994 | EP0614907A1 Dinucleotide and oligonucleotide analogues |
09/14/1994 | EP0614905A1 Erythromycin derivatives, their process of preparation and their application as medicaments |
09/14/1994 | EP0614659A2 Pharmaceutical compositions in semisolid form and a device for administration thereof |
09/14/1994 | EP0614488A1 Recombinant vaccine against lyme disease |
09/14/1994 | EP0614486A1 Targeted delivery of virus vector to mammalian cells |
09/14/1994 | EP0614457A1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments. |
09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
09/14/1994 | EP0614372A1 Cd8?+ cell antiviral factor |
09/14/1994 | EP0614371A1 Pasteurella multocida toxoid vaccines |
09/14/1994 | EP0614369A1 Pharmaceutical dipeptide compositions and methods of use thereof |
09/14/1994 | EP0614364A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin |
09/14/1994 | EP0614357A1 Immunopotentiatory agents |
09/14/1994 | EP0339040B1 Swine dysentery vaccine |
09/14/1994 | CN1091979A Immune serum globulin for intravenous injection and preparing method thereof |
09/14/1994 | CN1091953A Cantharidate antiviral pharmaceutical and its preparation |
09/13/1994 | US5347001 Oxidation of thio compound in presence of alkali metal tungstate |
09/13/1994 | US5346913 N-iodopropargyl hydantoin compounds, compositions, preparation, and use as antimicrobial agents |
09/13/1994 | US5346905 Induce interferon biosynthesis; viricides, effective against herpes virus; immunomodulators |
09/13/1994 | US5346696 Recombinent Interferon |
09/13/1994 | CA2118876A1 2,4-diamino-3-hydroxycarboxylic acid derivatives |
09/12/1994 | CA2118661A1 Acyloxyhexanoic acid derivatives |
09/10/1994 | CA2117214A1 Treatment of viral infections |
09/07/1994 | EP0613944A2 Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules |
09/07/1994 | EP0613498A1 Receptor derivates with binding sites for human rhinoviruses |
09/07/1994 | EP0613484A1 Bactericidal product, pharmaceutical composition containing same and food additive |
09/07/1994 | EP0613483A1 New lupane derivatives, preparation thereof and pharmaceutical compositions containing them |
09/07/1994 | EP0613480A1 Process for the preparation of cephem derivatives |
09/07/1994 | EP0613379A1 Therapeutic compounds |
09/07/1994 | EP0613378A1 Induction of protection against viral infection by synergy between viral proteins and viral peptides |
09/07/1994 | EP0613375A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
09/07/1994 | EP0613374A1 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
09/07/1994 | EP0462210B1 Vaccines for nontypable haemophilus influenzae |
09/07/1994 | EP0457848B1 Treatment of ventilator dependency with growth hormone |
09/07/1994 | EP0440642B1 Rifapentine hydrohalides |
09/07/1994 | CN1091733A Anti-androgenic cyclo and bicyclo alkenes |
09/07/1994 | CN1025852C Preparation of dizazbicyclic intermediates |
09/07/1994 | CA2117009A1 Dinucleotide and olignucleotide analogues |
09/06/1994 | US5344915 Proteins and the preparation thereof |
09/06/1994 | US5344833 Oxepane isomers of rapamycin useful as immunosuppressive agents |
09/06/1994 | US5344774 Human intracisternal A-type retroviral particles associated with sjogren's syndrome |
09/06/1994 | CA2114168A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
09/01/1994 | WO1994019346A1 Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria |
09/01/1994 | WO1994019329A1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
09/01/1994 | WO1994019321A1 Inhibitors of hiv reverse transcriptase |
09/01/1994 | WO1994019023A1 Cyclobutyl antisense oligonucleotides, methods of making and use thereof |
09/01/1994 | WO1994019011A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
09/01/1994 | WO1994019008A1 Combinations of retroviral inhibitors |
09/01/1994 | WO1994018986A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
09/01/1994 | WO1994018979A2 Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs |
09/01/1994 | WO1994018978A1 Substituted azolone derivatives for treating diseases caused by helicobacter |